| Typicality: | 0.231 |
| Saliency: | 0.335 |
| to the fda | 5 | transitive-object |
| prior to launch | 4 | temporal |
| through comparative testing against predicate devices | 4 | manner |
| manufacturer → prove → efficacy | 10 |
| manufacturer → prove → effectiveness | 9 |
| manufacturer → demonstrate → efficacy | 5 |
| negative | neutral | positive |
| 0.141 | 0.724 | 0.135 |
| Raw frequency | 24 |
| Normalized frequency | 0.335 |
| Modifier score | 0.000 |
| Perplexity | 343.171 |